Top 5 Takeaways Significant Reduction in Human Cases: Human dracunculiasis (Guinea worm disease) cases decreased to 15 in 2021 and three in the first half of 2022, continuing the decline

Top 5 Takeaways Increased Hospitalization Rates: During the Omicron variant-predominant periods, hospitalization rates among infants aged <6 months increased compared to the Delta variant period, but severe disease indicators among

Top 5 Takeaways Perception vs Reality: Half of the surveyed adults in Michigan and Illinois who had recent SARS-CoV-2 infections perceived local COVID-19 transmission as low or moderate, despite high

Top 5 Takeaways Low Vaccination Rates Among Young Children: As of July 2022, only 4% of children aged 6 months–4 years had received at least one dose of the COVID-19

Top 5 Takeaways Global Impact of Measles Vaccination: From 2000 to 2021, measles vaccination averted an estimated 56 million deaths globally. Despite this success, measles vaccination coverage has declined, particularly

Top 5 Takeaways 1. PRIORIX, a new MMR (Measles, Mumps, and Rubella) vaccine, has been licensed and recommended by the Advisory Committee on Immunization Practices (ACIP) in the United States

Top 5 Takeaways 1. 41.6% of adults had antibodies indicating past SARS-CoV-2 infection during August 2021–May 2022, with 43.7% potentially asymptomatic. 2. Seropositivity without vaccination was more common among younger

Top 5 Takeaways Paxlovid, an outpatient antiviral medication, is linked to a 51% reduction in hospitalization rates for COVID-19 among U.S. adults when prescribed within 5 days of diagnosis. This

Top 5 Takeaways Bivalent Boosters’ Effectiveness: The study reveals that bivalent mRNA COVID-19 boosters offer significant additional protection against symptomatic SARS-CoV-2 infection, especially for those who had 2 to 4